Stay updated on Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAccess to the NICARAGUA study record now shows a 403 Forbidden error, replacing the study details with an access-denied message.SummaryDifference19%

- Check35 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, indicating a new release of the site template. This update reflects a platform-level change rather than modifications to the study data or content.SummaryDifference0.1%

- Check42 days agoChange DetectedA new line '2017 ( U.S. NIH Grant/Contract )' was added to the list of Other Study ID Numbers in the study record. This addition provides NIH funding metadata for the NICARAGUA trial.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a small platform update to the study page. This reflects an underlying system update rather than a modification to the study data.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the Study Details page. This reflects an internal refresh rather than substantive changes to the study data.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2, indicating a small update to the page software.SummaryDifference0.1%

Stay in the know with updates to Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.